mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.2 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.2 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.066 |
0.2 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.2 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.2 |